FGF2 and prostate carcinoma: Previous observations had shown that FGF8b and FGF2 play a key role in prostate cancer and that PTX3 overexpression inhibits the FGF8b/FGF2-driven growth of TRAMP-C2 tumors [15], an androgen-responsive murine model of prostate carcinoma [22].